Modulating the innate immune response against brain tumor cells using anti-CD47 Abs showed promising results in treatment of multiple brain tumor types in preclinical studies, including GBM.4, , –7 CD47 is a ubiquitous protein expressed on the surface of most tumor cells. Here, CD47 is linked to brain neoplasm.